GlaxoSmithKline to acquire Tesaro
MLex Summary: London-based GlaxoSmithKline said today it will acquire Waltham, Massachusetts-based Tesaro for $5.1 billion. The transaction between the pharmaceutical giant and oncology-focused company is expected to close in the first...To view the full article, register now.
Already a subscriber? Click here to view full article